Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 公司是以儿科用药为发展特色，主要从事中成药及化学药品的研发、生产和销售、具备完整制药产业链的高新技术企业，产品应用范围涵盖呼吸系统类、消化系统类、全身抗感染类等多个用药领域。公司主要产品为小儿肺热咳喘颗粒、注射用盐酸溴己新、复方板蓝根颗粒、克咳片等呼吸系统制剂；奥美拉唑肠溶胶囊、肠炎宁（胶囊及颗粒）、注射用奥美拉唑钠、注射用二氯醋酸二异丙胺葡萄糖酸钠等消化系统制剂；头孢克肟分散片、注射用氨曲南、注射用克林霉素磷酸酯等全身抗感染类制剂；以及少部分妇科用药、心血管系统用药、神经性系统用药制剂产品。 公司在儿科制药领域具有较强的综合实力，是中国中药协会副会长单位、中国医药物资协会副会长单位、中华中医药学会儿科分会副主任委员单位及中国中药协会中西医融合儿童健康与药物研究专业委员会副主任委员单位。截至目前，公司共拥有295项药品批准文号，其中57种产品进入国家基本药物目录，96种产品进入国家医保目录，其中公司生产的化积片、尼美舒利缓释胶囊为独家剂型产品，小儿肺热咳喘颗粒（4g）、肠炎宁胶囊（每粒装0.3g）、肠炎宁颗粒（每袋装2g）为独家规格产品；公司核心产品小儿肺热咳喘颗粒（4g）已纳入国家基本药物目录和国家医保目录，肠炎宁颗粒（每袋装2g）已纳入国家医保目录。目前，公司小儿肺热咳喘产品和肠炎宁产品在OTC市场占有率位居行业第二。 目前公司拥有海口药谷、海口保税区、广西南宁、广西来宾、河北承德、广东遂溪六个智能化、标准化生产基地，逾40条中药及化药专业生产线，并构建了以“葫芦娃”、“葫芦爸”、“葫芦妈”三大品牌为主体的葫芦世家系列产品群。公司实行GMP、国际ISO9001和ICHQ10等多重质量保证体系，在生产工艺标准化的条件下，通过智能制造技术体系与装备的成熟应用，实现数字化、信息化、自动化生产，并通过在线记录、在线自动抽检和封闭式自检确保药品品质，为公司产品品质赢得了良好的市场声誉。 公司近年来不断加大研发投入，大力推进药品研发，通过设立专业研发机构、组建专业研发团队，积极推进合作研发，依托海南省中药制剂工程技术研究中心、院士专家工作站，公司研发实力和产品创新能力不断增强。目前，公司已经拥有73个知识产权专利。自2010年开始，公司连续通过了高新技术企业认定，连续两届入选中华中医药学会儿科分会副主任委员单位，随着科研持续创新，科技竞争力不断转化为市场竞争力，公司逐步奠定了在儿童呼吸系统疾病治疗领域优势地位。
Main Business 从事中成药及化学药品的研发、生产和销售，产品应用范围涵盖呼吸系统类、消化系统类、全身抗感染类等多个用药领域。
Legal Representative 刘景萍
Top Executives
董事长：刘景萍
董事：李君玲,于汇,汤琪波
独立董事：王桂华,王世贤,刘秋云
Top 5 Shareholder
Shareholder name Nature Holding Date
海南葫芦娃投资发展有限公司流通A股41.76%31/03/2024
浙江孚旺钜德健康发展有限公司流通A股14.38%31/03/2024
杭州中嘉瑞管理合伙企业（有限合伙）流通A股8.21%31/03/2024
卢锦华流通A股4.89%31/03/2024
汤杰丞流通A股4.70%31/03/2024
Company Secretary 王清涛
Solicitors 北京国枫律师事务所
Auditors 天健会计师事务所（特殊普通合伙）
Tel No 0898-68634767
Fax No 0898-68631245
Website huluwayaoye.com
Email huluwa@huluwayaoye.com
Company Address
Register: 海南省海口市海口国家高新区药谷工业园二期药谷四路8号
Office: 海南省海口市秀英区安读一路30号
Listing Date 10/07/2020
Shares Capital
Shares Capital: 400,108,752
Total A Share: 400,108,752
Listed A Share: 400,108,752
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.270
DPS(RMB)* ¥ 0.125
NBV Per Share(RMB)* ¥ 2.800
Market Capitalization(RMB) 4.729B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.